PAVmed Inc.
PAVM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6 | $30 | $43 | $191 |
| - Cash | $1 | $20 | $40 | $77 |
| + Debt | $32 | $49 | $37 | $0 |
| Enterprise Value | $37 | $59 | $40 | $113 |
| Revenue | $3 | $2 | $0 | $1 |
| % Growth | 22.1% | 550.4% | -24.6% | – |
| Gross Profit | -$3 | -$4 | -$3 | -$0 |
| % Margin | -101.6% | -161.8% | -858.6% | -17% |
| EBITDA | $30 | -$76 | -$100 | -$56 |
| % Margin | 990.7% | -3,089% | -26,392.6% | -11,180% |
| Net Income | $40 | -$64 | -$89 | -$50 |
| % Margin | 1,328.6% | -2,617.3% | -23,602.9% | -10,069.4% |
| EPS Diluted | 0.496 | -9.164 | -15.032 | -9.797 |
| % Growth | 105.4% | 39% | -53.4% | – |
| Operating Cash Flow | -$34 | -$52 | -$71 | -$41 |
| Capital Expenditures | -$0 | -$0 | -$2 | -$1 |
| Free Cash Flow | -$34 | -$52 | -$73 | -$42 |